← Back to directory

Anna Maria Langkilde

Researcher Next ID · RN-006200

Researcher · Medicine

AstraZeneca (Brazil)

São Paulo, Brazil

Not currently recruitingFunding unknown
Works count
310
Citation count
22,831
H-index
75
i10-index
174

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Diabetes Treatment and Management
Pancreatic function and diabetes
Cardiovascular Function and Risk Factors
Hyperglycemia and glycemic control in critically ill and hospitalized patients
Metabolism, Diabetes, and Cancer

Publications

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2206286

  • Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

    The Journal of Clinical Endocrinology & Metabolism · 2012 · https://doi.org/10.1210/jc.2011-2260

Current projects

    No projects listed.